X @Forbes
Forbes·2026-03-01 10:30
For labs at universities, biotech firms and big pharma companies alike, AI models are offering new possibilities for drug discovery.Using those models, though, is rarely as simple as using a chatbot. They are generally fitted to different tasks, whether that’s predicting protein structures, optimizing chemical reactions or any of the other myriad tasks involved in researching new medicine. What’s more, they typically require additional training and a level of machine learning sophistication that many biolog ...